Napoleon-Register

Nicht-interventionelle Beobachtungsstudie zur Behandlung der akuten Promyelozytenleukämie (APL) Das Register soll einen detaillierten Einblick in die Charakteristika und das Management von APL-Patienten im klinischen Alltag liefern. Ferner sollen Informationen über Langzeitwirkungen der Therapien sowie über die Lebensqualität der Patienten erhoben werden. Des Weiteren ist die Asservierung von Biomaterial für translationale Studien im Rahmen der Studiengruppen spezifischen Konzepten vorgesehen.

{ "short_title": "Napoleon-Register", "data_mode": "900", "data_mode_number": "000000841", "official_title": null, "accrual_state": "running", "therapeutic_value": "not_applicable", "therapieansatz_value": "not_applicable", "therapieintervention_value": "not_applicable", "therapielinie_value": "first", "ctgov_number": null, "eudract_number": null, "general_contact_email": "sal-aml-register@ukdd.de", "general_contact_phone": "+49 351-45818380", "hauptpruefer_dd_name": null, "description_laie_de": "Nicht-interventionelle Beobachtungsstudie zur Behandlung der akuten Promyelozytenleuk\u00e4mie (APL)\r\nDas\u00a0Register\u00a0soll\u00a0einen\u00a0detaillierten\u00a0Einblick\u00a0in\u00a0die\u00a0Charakteristika\u00a0und\u00a0das\u00a0Management\u00a0von\u00a0APL-Patienten\u00a0im\u00a0klinischen\u00a0Alltag\u00a0liefern.\u00a0\r\nFerner\u00a0sollen\u00a0Informationen\u00a0\u00fcber\u00a0Langzeitwirkungen\u00a0der\u00a0Therapien\u00a0sowie\u00a0\u00fcber\u00a0die\u00a0Lebensqualit\u00e4t\u00a0der\u00a0Patienten\u00a0erhoben\u00a0werden.\u00a0Des\u00a0\r\nWeiteren\u00a0ist\u00a0die\u00a0Asservierung\u00a0von\u00a0Biomaterial\u00a0f\u00fcr\u00a0translationale\u00a0Studien\u00a0im\u00a0Rahmen\u00a0der\u00a0Studiengruppen\u00a0spezifischen\u00a0Konzepten\u00a0\r\nvorgesehen.\u00a0", "description_laie_en": "Non-interventional\u00a0observational\u00a0study\u00a0for\u00a0the\u00a0treatment\u00a0of\u00a0acute\u00a0promyelocytic\u00a0leukemia\u00a0(APL). The\u00a0registry\u00a0aims\u00a0to\u00a0document\u00a0epidemiologic\u00a0data,\u00a0treatment\u00a0and\u00a0long-term\u00a0outcome\u00a0as\u00a0well\u00a0as\u00a0quality\u00a0of\u00a0life\u00a0of\u00a0patients\u00a0with\u00a0APL.\u00a0Additionally,\u00a0a\u00a0biobanking\u00a0project\u00a0for\u00a0further\u00a0translational\u00a0studies\u00a0is\u00a0integrated.\u00a0", "description_expert_de": "Nicht-interventionelle Beobachtungsstudie zur Behandlung der akuten Promyelozytenleuk\u00e4mie (APL)\r\nDas\u00a0Register\u00a0soll\u00a0einen\u00a0detaillierten\u00a0Einblick\u00a0in\u00a0die\u00a0Charakteristika\u00a0und\u00a0das\u00a0Management\u00a0von\u00a0APL-Patienten\u00a0im\u00a0klinischen\u00a0Alltag\u00a0liefern.\u00a0\r\nFerner\u00a0sollen\u00a0Informationen\u00a0\u00fcber\u00a0Langzeitwirkungen\u00a0der\u00a0Therapien\u00a0sowie\u00a0\u00fcber\u00a0die\u00a0Lebensqualit\u00e4t\u00a0der\u00a0Patienten\u00a0erhoben\u00a0werden.\u00a0Des\u00a0\r\nWeiteren\u00a0ist\u00a0die\u00a0Asservierung\u00a0von\u00a0Biomaterial\u00a0f\u00fcr\u00a0translationale\u00a0Studien\u00a0im\u00a0Rahmen\u00a0der\u00a0Studiengruppen\u00a0spezifischen\u00a0Konzepten\u00a0\r\nvorgesehen.\u00a0", "description_expert_en": "Non-interventional\u00a0observational\u00a0study\u00a0for\u00a0the\u00a0treatment\u00a0of\u00a0acute\u00a0promyelocytic\u00a0leukemia\u00a0(APL). The\u00a0registry\u00a0aims\u00a0to\u00a0document\u00a0epidemiologic\u00a0data,\u00a0treatment\u00a0and\u00a0long-term\u00a0outcome\u00a0as\u00a0well\u00a0as\u00a0quality\u00a0of\u00a0life\u00a0of\u00a0patients\u00a0with\u00a0APL.\u00a0Additionally,\u00a0a\u00a0biobanking\u00a0project\u00a0for\u00a0further\u00a0translational\u00a0studies\u00a0is\u00a0integrated.\u00a0", "rechtsgrundlage_value": "BO", "phase_amg_value": null, "main_cat_id": 4, "sub_cat_id": 30 }